Pharmacokinetic dosing in prophylactic treatment of hemophilia A

European Journal of Haematology

Volumn 51, Issue 4, 1993, Pages 247-252

  Carlsson, M ^a,b   Berntorp, E ^c   Bjorkman S ^a   Lindvall, K ^c  

^a Hospital Pharmacy   (Sweden)

^b Dept of Community Health Sciences ^*  (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

dosage; factor VIII; hemophilia A; pharmacokinetics; prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL;

ADULT; AGED; COMPUTER SIMULATION; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMAN; KINETICS; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0027145071     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1993.tb00638.x     Document Type: Article

References (13)

1. Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B
2. Clinical pharmacokinetics of factor VIII in patients with classic haemophilia
3. Multi‐variate analysis of factors govering the pharmacokinetics of exogenous factor VIII in haemophiliacs
4. Pharmacokinetics of factor VIII in humans – obtaining clinically relevant data from comparative studies
5. Assay of factor VIII:C with a chromogenic substrate
6. Statistical estimations in pharmacokinetics
7. A calculator program for individualizing factor VIII dosage
8. Individualization of factor VIII dosage
9. Haemophilia in Sweden; VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B
10. Hemophilia prophylaxis with factor VIII concentrate
11. Hemophilia A prophylaxis with factor VIII concentrate in a home‐treatment program: a controlled study
12. Arthropathy in children with severe hemophilia A
13. Prophylaxis with factor concentrates in preventing hemophilic arthropathy